Life Sciences

Healthcare

Salt AI Secures $10M to Shape Next Era of Contextual AI

Salt AI, a leading provider of contextual AI solutions for enterprise applications in life sciences and health technology, has announced a $10 million funding...

Healthcare

Lunit & Agilent Partner to Advance AI-Powered Diagnostic Solutions

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing & enhance precision medicine capabilities Lunit, a leading provider of artificial intelligence...

Healthcare

Pfizer to Acquire Metsera and Its Obesity Pipeline

Pfizer Inc. and Metsera, Inc. announced that they have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company...

Healthcare

Causaly Launches Agentic Research for Life Sciences R&D

Causaly announced the launch of Agentic Research, a groundbreaking platform of multi-autonomous AI research agents designed specifically for life sciences research and development (R&D)....

Healthcare

LabConnect & OmniScience launch agentic AI for trial data

LabConnect, a global leader in central laboratory services, has announced a strategic collaboration with OmniScience, the AI company behind Vivo, the industry’s first agent-based...

Healthcare

Lila Sciences Secures $235M to Expand AI Research Program

Lila Sciences announced a significant new funding round in which investors have committed US$235 million to broaden its AI science program. The company will...

Healthcare

Lilly Launches TuneLab: Empowering Biotech Startups with AI-Driven Drug Discovery

Eli Lilly and Company has introduced TuneLab, an advanced artificial intelligence (AI) and machine learning (ML) platform designed to provide biotechnology startups with access...

Healthcare

Ketryx Raises $39M Series B to Advance AI in Life Sciences

Ketryx, the AI-driven compliance platform that helps life sciences companies bring safer products to market faster, announced it has raised $39 million in a...

Healthcare

Enveda Secures $150M Series D, Achieves Unicorn Status, and Advances AI-Driven Drug Discovery

Enveda Biosciences, a clinical-stage biotech company specializing in AI-powered drug discovery from natural compounds, has announced a $150 million Series D funding round, propelling...